Effect of Melatonin on Cardiometabolic Risk- FULL

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

Also called NCT02681887

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose basic science
Phase
Phase 3
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02681887
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02681887. Randomized; double masking; primary purpose basic science. Start 2016-09 (actual); primary completion 2021-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect of Melatonin on Cardiometabolic Risk- FULL
Condition
Obesity
Condition
Prediabetic State
Intervention (Drug)
Melatonin
Intervention (Drug)
Placebo
Lead sponsor
Brigham and Women's Hospital (class: other)

Record details

Record id
cardio:ct-nct02681887
Content hash
82fb0274eab7468153f540465ae46d245d1fad98e8abf32b8abf598f94207064